976 followers
RT @IanARowe: Higher tumour burden and AFP in Tac group in this trial. 1-year outcomes only. RCT of sirolimus in patients with HCC showed…
RT @IanARowe: Higher tumour burden and AFP in Tac group in this trial. 1-year outcomes only. RCT of sirolimus in patients with HCC showed…
Higher tumour burden and AFP in Tac group in this trial. 1-year outcomes only. RCT of sirolimus in patients with HCC showed possible early benefit on recurrence but ultimately no benefit (https://t.co/yxlZLf2dKv). No good evidence not to use Tac for …
RT @TransplantJrnl: Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase…
RT @TransplantJrnl: Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase…